Arbor Biotechnologies

Devyn Smith, Ph.D., CEO

Oct. 14 | 10:00am | BlueRock Therapeutics Ballroom

Cambridge, MA
(Private)

In-person Presentation
Arbor Biotechnologies operates in the healthcare industry focusing on biotechnology business. The company was founded in 2016 and is headquartered in Cambridge, Massachusetts. We are discovering, developing, and making the next generation of genetic medicines available to all patients. We are disrupting the field through our differentiated genetic editing and delivery capabilities, developed using a proprietary discovery engine. We own a unique portfolio of CRISPR-based genetic modifiers that can be tailored to correct the underlying pathology of each genetic disease. Our pipeline of genetic medicines will be focused on bringing cures to all patients with genetic disease.
www.arbor.bio.com



By using this website you agree to accept our Privacy Policy and Terms & Conditions